Huadong Medicine Secures Exclusive Rights to Arcutis’ Daxas in Greater China and South-East Asia
Huadong Medicine Co., Ltd (SHE: 000963) has announced a significant licensing agreement with Arcutis (NASDAQ:...
Medtronic Partners with APMG to Advance Orthopedic Treatment Services in China
US-based Medtronic Inc., (NYSE: MDT) has entered into a partnership with China’s private healthcare group...
Everest Medicines and Shanghai Pharmaceuticals Deepen Partnership for Drug Distribution in China
China-based Everest Medicines (HKG: 1952) has announced a strategic partnership with Shanghai Pharmaceuticals marking a...
NMPA Greenlights Oricell Therapeutics’ OriCAR-017 for Clinical Trials in Multiple Myeloma
The National Medical Products Administration (NMPA) has indicated on its website that Oricell Therapeutics Co.,...
Beijing Balance Medical Receives Approval for Innovative Expandable Artificial Heart Valve in China
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a leading medical technology company in China,...
WuXi Biologics and Boostimmune Forge Exclusive R&D Partnership
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced a...
Antengene Corp. Secures Licensing Deal with Hansoh Pharmaceutical for Xpovio in China
China-based biopharmaceutical company Antengene Corp., Ltd (HKG: 6996) has announced a significant licensing agreement with...
Novo Nordisk’s H1 2023 Financials Show 30% YOY Growth Driven by GLP-1 Drugs and Obesity Sales
Denmark-based pharmaceutical company Novo Nordisk A/S (NYSE: NVO) has announced its financial results for the...
Pfizer Faces Whistleblower Lawsuit Over Alleged FCPA Violations in China
A former employee of Pfizer Inc., (NYSE: PFE), Frank Han, has filed a civil lawsuit...
Organon Reports Q2 2023 Revenue Growth, Driven by Women’s Health and Biosimilars
US-based Organon (NYSE: OGN) has reported its financial results for the second quarter of 2023,...
Regeneron Pharmaceuticals Acquires Decibel Therapeutics for Hearing Loss Gene Therapies
US-based biopharmaceutical company Regeneron Pharmaceuticals Inc., (NASDAQ: REGN) has announced the acquisition of fellow US...
Denali Therapeutics and Takeda Halt Development of Alzheimer’s Drug Candidate TAK-920/DNL919
US-based biopharmaceutical company Denali Therapeutics Inc., (NASDAQ: DNLI) has announced in its Q2 2023 financial...
Poseida Therapeutics Secures $50 Million Investment from Astellas for Cell and Gene Therapy
US-based cell and gene therapy developer Poseida Therapeutics, Inc. (NASDAQ: PSTX) has announced a significant...
Lee’s Pharmaceutical’s Subsidiary Completes Phase III Study for Myopia Treatment NVK002
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has announced...
Eyebright Medical Technology’s Intraocular Lenses Earn Fast-Track Status in China
Beijing-based Eyebright Medical Technology Co., Ltd (SHE: 688050) has announced that its “intraocular lenses with...
Neurophth Biotechnology Secures RMB700 Million in Series C+ Financing for Gene Therapy Development
China-based gene therapy specialist Neurophth Biotechnology Ltd has reportedly secured close to RMB700 million in...
Novartis Reports Positive Phase III Results for Remibrutinib in Chronic Spontaneous Urticaria
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has announced positive data from the Phase III...
Burning Rock Partners with AstraZeneca to Develop Companion Diagnostics for Cancer Therapies
Guangzhou-based medical device giant Burning Rock (NASDAQ: BNR) has announced a strategic partnership with AstraZeneca...
Audit Reveals Illicit Payments and Inflated Prices in Pharmaceutical Industry
An audit has shed light on the use of third-party business promotion companies as a...
Eli Lilly & Co. Reports 28% YOY Revenue Increase in Q2 2023 Financials
US pharmaceutical giant Eli Lilly & Co., (NYSE: LLY) has released its financial results for...